Cargando…
Development and validation of a glioma-associated mesenchymal stem cell-related gene prognostic index for predicting prognosis and guiding individualized therapy in glioma
BACKGROUND: Recent studies have demonstrated that glioma-associated mesenchymal stem cells (GA-MSCs) are implicated in the regulation of glioma malignant progression. However, the prognostic value of GA-MSCs has not been comprehensively explored in glioma. METHODS: We extracted GA-MSCs from glioma t...
Autores principales: | Peng, Zesheng, Wu, Yuxi, Wang, Jiajing, Gu, Sujie, Wang, Yihao, Xue, Bingzhou, Fu, Peng, Xiang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068170/ https://www.ncbi.nlm.nih.gov/pubmed/37005685 http://dx.doi.org/10.1186/s13287-023-03285-9 |
Ejemplares similares
-
COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021) -
A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas
por: Wu, Yuxi, et al.
Publicado: (2022) -
Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification
por: Peng, Zesheng, et al.
Publicado: (2023) -
Identifying the Hub Genes of Glioma Peritumoral Brain Edema Using Bioinformatical Methods
por: Wu, Yuxi, et al.
Publicado: (2022) -
Remodelling and Treatment of the Blood-Brain Barrier in Glioma
por: Wang, Yihao, et al.
Publicado: (2021)